Tongzhen Xu

State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Spatial Heterogeneity of Intratumoral Microbiota and Its Roles in Tumor-Microbiota Interactions and Therapeutic Implications.

Spatial Heterogeneity of Intratumoral Microbiota and Its Roles in Tumor-Microbiota Interactions and Therapeutic Implications.

Journal: Pathogens (Basel, Switzerland)

Published: May 22, 2026

Dose-Escalated Versus Standard Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Nine-Year Results of a Randomized Phase 2 Trial.

Dose-Escalated Versus Standard Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Nine-Year Results of a Randomized Phase 2 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: April 14, 2026

Real-world clinical impact of implementing and updating a deep learning-based automatic contouring system in rectal cancer radiotherapy.

Real-world clinical impact of implementing and updating a deep learning-based automatic contouring system in rectal cancer radiotherapy.

Journal: Journal of applied clinical medical physics

Published: February 22, 2026

Diabetes and Performance Status Predict Severe, Persistent Radiation Proctitis: Long-Term Endoscopic Findings From STELLAR Trial.

Diabetes and Performance Status Predict Severe, Persistent Radiation Proctitis: Long-Term Endoscopic Findings From STELLAR Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 11, 2026

Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response Prediction.

Identification of Oral Microbiome Biomarkers Associated with Lung Cancer Diagnosis and Radiotherapy Response Prediction.

Journal: Pathogens (Basel, Switzerland)

Published: October 31, 2025

Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy.

Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy.

Journal: BMC cancer

Published: October 30, 2025

Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trial.

Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trial.

Journal: BMC medicine

Published: October 15, 2025

Quality of Life and Functional Outcomes in Patients With Locally Advanced Rectal Cancer Receiving Total Neoadjuvant Therapy Versus Concurrent Chemoradiation Therapy: An Analysis of the STELLAR Trial.

Quality of Life and Functional Outcomes in Patients With Locally Advanced Rectal Cancer Receiving Total Neoadjuvant Therapy Versus Concurrent Chemoradiation Therapy: An Analysis of the STELLAR Trial.

Journal: International journal of radiation oncology, biology, physics

Published: June 25, 2024

Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial.

Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 03, 2024

The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.

The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.

Journal: BMC cancer

Published: September 24, 2023

Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.

Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.

Journal: Frontiers in immunology

Published: March 25, 2023

Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.

Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.

Journal: Frontiers in immunology

Published: September 07, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026